Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Persistence of viral reservoirs in multiple tissues after antiretroviral therapy suppression in a macaque RT-SHIV model.

Kline C, Ndjomou J, Franks T, Kiser R, Coalter V, Smedley J, Piatak M Jr, Mellors JW, Lifson JD, Ambrose Z.

PLoS One. 2013 Dec 18;8(12):e84275. doi: 10.1371/journal.pone.0084275. eCollection 2013.

PMID:
24367650
[PubMed - in process]
Free PMC Article
2.

Viral sanctuaries during highly active antiretroviral therapy in a nonhuman primate model for AIDS.

North TW, Higgins J, Deere JD, Hayes TL, Villalobos A, Adamson L, Shacklett BL, Schinazi RF, Luciw PA.

J Virol. 2010 Mar;84(6):2913-22. doi: 10.1128/JVI.02356-09. Epub 2009 Dec 23.

PMID:
20032180
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.

Shen A, Zink MC, Mankowski JL, Chadwick K, Margolick JB, Carruth LM, Li M, Clements JE, Siliciano RF.

J Virol. 2003 Apr;77(8):4938-49.

PMID:
12663799
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel.

Cranage M, Sharpe S, Herrera C, Cope A, Dennis M, Berry N, Ham C, Heeney J, Rezk N, Kashuba A, Anton P, McGowan I, Shattock R.

PLoS Med. 2008 Aug 5;5(8):e157; discussion e157. doi: 10.1371/journal.pmed.0050157.

PMID:
18684007
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Viral decay kinetics in the highly active antiretroviral therapy-treated rhesus macaque model of AIDS.

Deere JD, Higgins J, Cannavo E, Villalobos A, Adamson L, Fromentin E, Schinazi RF, Luciw PA, North TW.

PLoS One. 2010 Jul 23;5(7):e11640. doi: 10.1371/journal.pone.0011640.

PMID:
20668516
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

RT-SHIV, an infectious CCR5-tropic chimeric virus suitable for evaluating HIV reverse transcriptase inhibitors in macaque models.

Jiang Y, Tian B, Saifuddin M, Agy MB, Emau P, Cairns JS, Tsai CC.

AIDS Res Ther. 2009 Nov 5;6:23. doi: 10.1186/1742-6405-6-23.

PMID:
19891783
[PubMed]
Free PMC Article
7.

Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques.

Malzahn J, Shen C, Caruso L, Ghosh P, Sankapal SR, Barratt-Boyes S, Gupta P, Chen Y.

Virol J. 2012 Nov 14;9:269. doi: 10.1186/1743-422X-9-269.

PMID:
23150992
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile.

Haigwood NL, Watson A, Sutton WF, McClure J, Lewis A, Ranchalis J, Travis B, Voss G, Letvin NL, Hu SL, Hirsch VM, Johnson PR.

Immunol Lett. 1996 Jun;51(1-2):107-14.

PMID:
8811353
[PubMed - indexed for MEDLINE]
9.

Residual viremia in an RT-SHIV rhesus macaque HAART model marked by the presence of a predominant plasma clone and a lack of viral evolution.

Kauffman RC, Villalobos A, Bowen JH, Adamson L, Schinazi RF.

PLoS One. 2014 Feb 5;9(2):e88258. doi: 10.1371/journal.pone.0088258. eCollection 2014.

PMID:
24505452
[PubMed - in process]
Free PMC Article
10.

Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy.

Kearney M, Spindler J, Shao W, Maldarelli F, Palmer S, Hu SL, Lifson JD, KewalRamani VN, Mellors JW, Coffin JM, Ambrose Z.

J Virol. 2011 Jan;85(2):1067-76. doi: 10.1128/JVI.01701-10. Epub 2010 Nov 17.

PMID:
21084490
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication.

Chun TW, Justement JS, Murray D, Hallahan CW, Maenza J, Collier AC, Sheth PM, Kaul R, Ostrowski M, Moir S, Kovacs C, Fauci AS.

AIDS. 2010 Nov 27;24(18):2803-8. doi: 10.1097/QAD.0b013e328340a239.

PMID:
20962613
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A simian immunodeficiency virus-infected macaque model to study viral reservoirs that persist during highly active antiretroviral therapy.

Dinoso JB, Rabi SA, Blankson JN, Gama L, Mankowski JL, Siliciano RF, Zink MC, Clements JE.

J Virol. 2009 Sep;83(18):9247-57. doi: 10.1128/JVI.00840-09. Epub 2009 Jul 1.

PMID:
19570871
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

Metzner KJ, Binley JM, Gettie A, Marx P, Nixon DF, Connor RI.

Retrovirology. 2006 Dec 21;3:97.

PMID:
17184540
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Analysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAART.

Deere JD, Kauffman RC, Cannavo E, Higgins J, Villalobos A, Adamson L, Schinazi RF, Luciw PA, North TW.

PLoS One. 2014 Feb 5;9(2):e87914. doi: 10.1371/journal.pone.0087914. eCollection 2014.

PMID:
24505331
[PubMed - in process]
Free PMC Article
15.

Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination.

Sellier P, Mannioui A, Bourry O, Dereuddre-Bosquet N, Delache B, Brochard P, Calvo J, Prévot S, Roques P.

PLoS One. 2010 May 11;5(5):e10570. doi: 10.1371/journal.pone.0010570.

PMID:
20485497
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Generation of a dual RT Env SHIV that is infectious in rhesus macaques.

Smith JM, Dauner A, Li B, Srinivasan P, Mitchell J, Hendry M, Ellenberger D, Butera S, Otten RA.

J Med Primatol. 2010 Aug;39(4):213-23. doi: 10.1111/j.1600-0684.2010.00434.x.

PMID:
20618587
[PubMed - indexed for MEDLINE]
17.

Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy.

Ambrose Z, Palmer S, Boltz VF, Kearney M, Larsen K, Polacino P, Flanary L, Oswald K, Piatak M Jr, Smedley J, Shao W, Bischofberger N, Maldarelli F, Kimata JT, Mellors JW, Hu SL, Coffin JM, Lifson JD, KewalRamani VN.

J Virol. 2007 Nov;81(22):12145-55. Epub 2007 Sep 12.

PMID:
17855539
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Molecular biological assessment methods and understanding the course of the HIV infection.

Katzenstein TL.

APMIS Suppl. 2003;(114):1-37. Review.

PMID:
14626050
[PubMed - indexed for MEDLINE]
19.

Studies on lymphoid tissue from HIV-infected individuals: implications for the design of therapeutic strategies.

Cohen OJ, Pantaleo G, Lam GK, Fauci AS.

Springer Semin Immunopathol. 1997;18(3):305-22. Review.

PMID:
9089951
[PubMed - indexed for MEDLINE]
20.

Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1.

Hofman MJ, Higgins J, Matthews TB, Pedersen NC, Tan C, Schinazi RF, North TW.

Antimicrob Agents Chemother. 2004 Sep;48(9):3483-90.

PMID:
15328115
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk